Litiasis Renal

Devicare launches Lit-Control® in the US with Diem Labs

 

 

 

 

 

Devicare is taking the leap into the US healthcare market with its new partner Diem Labs, LLC to introduce an innovative digital medical solution (DTx) in the urology field in the country.

The official launch of Lit-Control® take place in the American Urological Association Annual Meeting (BOOTH 3440), held from 3 to 6 May in Chicago, which […]

Devicare is preparing the largest round of crowdfunding on Capital Cell

Devicare is aiming to speed up its growth and will start a 1.5 million Euro crowdfunding round on Capital Cell, the funding platform that specialises in healthcare. With a 1,000 Euro minimum ticket, the company is looking to attract small investors, sponsors, patients and people knowledgeable about innovation and health.

Devicare is a technologically-driven company dedicated […]

Devicare participates in the leading lithiasis event in Spain and presents the results of the ‘Double J’ trial

February 7th, 2019

Devicare participated in the National Meeting of the Lithiasis, Endourology, Laparoscopy and Robotics Groups (LELR), held on 24 and 25 January in Palma de Mallorca. The plenary sessions focused on the medical and surgical handling of urinary lithiasis which affects 10% of the Spanish population. The final results of the “Double J” clinical […]

The ‘Double J’ clinical trial wins the Pedro Arregui award from the Spanish Urological Association

February 5th, 2019

During the 19th National Meeting of the Lithiasis, Endourology and Robotics Groups organised by the Spanish Urological Association on 24 and 25 January in Palma de Mallorca, Dr Jaime Fernández-Concha was recognised on behalf of the research team for the Multicenter, Controlled and Randomized clinical trial on urinary pH monitoring and nutraceutical intervention […]

Devicare announces the positive results of the clinical trial with Lit-Control® to prevent the encrustation of catheters in patients with lithiasis

Devicare and nine leading Spanish hospitals in urology have successfully completed the clinical trial which demonstrates the efficacy of the combined use of a medical device (Lit-Control® pH Meter) and a nutraceutical (Lit-Control® pH Down) to prevent the encrustation of double J catheters by monitoring urinary pH and supplying phytates (crystallisation inhibitors).

The results of this […]

Dr Carlos Torrecilla: “We have the solution to prevent the encrustation of double J catheters”

Interview

December 12, 2018

Dr Carlos Torrecilla, director of the Lithiasis Unit of the Bellvitge University Hospital and national coordinator of the Lithiasis and Endourology Group of the Spanish Association of Urology, is the principal investigator of a clinical trial sponsored by Devicare conducted in nine Spanish university hospitals (Bellvitge, La Paz, Río Hortega, Puigvert Foundation, San […]

Devicare and Exeltis signed an agreement to market the Lit-Control in Spain

The multinational company Exeltis and the digital therapeutics company Devicare have signed an agreement to market the Lit-Control® family of products in Spain. Lit-Control® is the world’s first digital therapeutics solution that allows the most common urological diseases to be prevented and treated effectively from home while also improving patients’ adherence to the treatment.

This collaboration […]

Devicare launches e-commerce site for Lit-Control® in Spain

Improving your urinary health is now easier thanks to the new website Lit-control.es. The e-commerce site, designed by Devicare’s digital marketing department, is completely patient-focused: detailed information on Lit-Control® products to monitor urinary pH levels, online purchases and a private area with different functionalities that provide improved know-how and patient empowerment in the management of […]

Devicare continues its expansion in Latin America

Devicare is moving forward in its international expansion by closing licensing and distribution agreements in Argentina, Uruguay and Peru. Various pharmaceutical companies will introduce the products from the Lit-Control® brand to improve the urinary healthcare of the residents of Latin America. The company had previously announced its entry into Mexico and Colombia.

At the end of […]

New treatments for kidney stones presented in the National Urology Congress

The LXXXIII National Urology Congress, which brought together more than one thousand urologists from 13 to 16 June in Gijón, focused its debate on different advances as a medical solution which will improve the diagnosis and treatment of lithiasis. Lithiasis (renal calculi or kidney stones) affects 10% of the Spanish population and this figure continues […]